Nevertheless, since CRCs with enhanced high nuclear CK2α expression do not show increased levels of p-MLH1 and significantly less somatic tumor mutations when compared to high nuclear/cytoplasmic CK2α-expressing CRCs, this assumption seems rather unlikely. Here, MLH1 is linked to neoplasm.